DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile

Atherosclerosis

Volumn 152, Issue 1, 2000, Pages 193-201

  Kamboh, M Ilyas ^a   Aston, Christopher E ^a   Hamman, Richard F ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

ApoC IV; Association; Genetic variation; Linkage disequilibrium; Lipid

Indexed keywords

APOLIPOPROTEIN; LIPID;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; DNA FLANKING REGION; EXON; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MOUSE; MULTIGENE FAMILY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSGENIC MOUSE;

ADULT; AGED; ALLELES; APOLIPOPROTEINS C; COMPARATIVE STUDY; DNA; FEMALE; GENE FREQUENCY; HUMAN; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; LIPIDS; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); POPULATION SURVEILLANCE; PROBABILITY; SENSITIVITY AND SPECIFICITY; SUPPORT, U.S. GOV'T, P.H.S.; VARIATION (GENETICS);

EID: 0034283324     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00459-1     Document Type: Article

References (18)

1. Allan C.M., Walker D., Segrest J.P., Taylor J.M. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics. 28:1995;291-300.
2. Allan C.M., Taylor S., Taylor J.M. Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster. J. Biol. Chem. 272:1997;29113-29119.
3. Allan C.M., Taylor J.M. Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice. J. Lipid Res. 37:1996;1510-1518.
4. Breslow J. Apoliprotein genetic variation and human disease. Physiol. Rev. 68:1988;85-132.
5. Humphries S.E. DNA polymorphism of the apolipoprotein gene: their use in investigating the genetic component of hyperlipidemia and atherosclerosis. Atherosclerosis. 72:1988;89-108.
6. Hamman R.F., Marshal J.A., Baxter J., Kahn L.R., Mayer E.J., Dolean M., Murphy J.R., Lezotte D.C. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am. J. Epidemiol. 129:1989;295-311.
7. Rewers M., Shetterly S.M., Hoag S., Marshall J., Hamman R.F. Is the risk of coronary heart disease lower in Hispanics than in non-Hispanic whites? The San Luis Valley Diabetes Study. Ethnicity Dis. 3:1993;44-54.
8. Thompson E.A., Deeb S., Walker D., Motulsky A.G. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 42:1988;113-124.
9. Kamboh M.I., Hamman R.F., Ferrell R.E. Two polymorphisms in the APOA-IV coding gene: their evolution and linkage disequilibrium. Genet. Epidemiol. 9:1992;305-315.
10. Boerwinkle E., Sing C.F. Bias of the contribution of single effects to the variance of a quantitative trait. Am. J. Hum. Genet. 39:1986;137-144.
11. Kamboh M.I., Aston C.E., Hamman R.F. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 112:1995;145-159.
12. Aalto-Setälä K., Fisher E.A., Chen X., Chajek-Shaul T., Hayek T., Zechner R., Walsh A., Ramakrishnan R., Ginsberg H.N., Breslow J.L. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low-density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particles. J. Clin. Invest. 90:1992;1889-1900.
13. de Silva H.V., Lauer S.J., Wang J., Simonet W.S., Weisgraber K.H., Mahley R.W., Taylor J.M. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269:1994;2324-2335.
14. Shachter N.S., Hayek T., Leff T., Smith J.D., Rosenberg D.W., Walsh A., Ramakrishnan R., Goldberg I.J., Ginsberg H.N., Breslow J.L. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J. Clin. Invest. 93:1994;1683-1690.
15. Simonet W.S., Bucay N., Pitas R.E., Lauer S.J., Taylor J.M. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266:1991;8651-8654.
16. Kamboh M.I., Aston C.E., Ferrell R.E., Hamman R.F. Impact of the apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis. 98:1993;201-211.
17. Hanis C.L., Hewett-Emmett D., Douglas T.C., Bertin J.K., Schull W.J. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Arterioscler. Thromb. 11:1991;362-370.
18. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.